Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma

NCT01080391 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

792

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed Multiple Myeloma

Interventions

DRUG: Dexamethasone
DRUG: Lenalidomide
DRUG: Carfilzomib

Sponsor

Amgen